Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So either business practices change and vet/hospitals use isopet/radiogel for the better of mankind and pps goes up OR major buyout happens and isopet/radiogel gets shelved and pps goes up on buyout.
Either way is good for me regarding financials but I’d hope mankind will benefit from this technology and it not be shelved
0.075-0.08 coming very soon
Volume and price accent will start soon!
Anybody want to run the numbers from 10k and show me how I’m missing it. Maybe I’m off , anyone want to help me understand? Show me the math please
From what I can see 81.5% is available to trade meaning 18.5% is unavailable. So roughly 360million * .815 leaves 293 million available
Didn’t isopet revenue double this year from last year?
Guessing we will find a new support around .0725-.075. I’d be surprised if we find the .08 support but is possible
You just listed the path so stop saying no clear path when obviously there is
Yep! Kinda like how the sellers get absorbed everyday by the buyers that know this is going to take off
Useless selling and healthy reset anyway can’t always go up
Agreed rdgl is primed and ready
Stair stepping to .075 today
Golden here. Big increase stair step imminent. Each day that passes just gets closer to approval
Precisely, now why would MK want to rush what the guidance is. That would only increase chances of errors. Therefore some individuals on here that complain about timing and ineptness need to chill as MK is following the guidance and making sure all that is required is submitted with no ability to refute the results of an excellent product
If the price is right Bob we will see $2.68 on the board!
Just hope for steady stair step between now and before we submit. Then bigger stair steps faster approaching inevitable APPROVAL
Only in 5th maybe 6th inning. But that’s fine, progress is progress
Board has its very own magic eight ball
Just read on FB they are trying to get a clinic opened in Canada as we speak
Depends how fast they get the final phase of qms done. Would like to hear a status of testing/results though.
Big updates coming soon
Juicy monthly coming up and collective super positive annual report around the corner
Right. Even if and big if they need another $2.5 million to get them another year that’s how many shares? 50million added to outstanding? Which puts rdgl at roughly 410 million total outstanding. Still has a potential easy valuation at $2-$3 pps
Lol
Around January 24th
Hopefully getting recap annual within a week or so
Appreciate the big dime but I’ll be happy to get to 8 again.
To many opinions that is trying to be portrayed as true. #FAKE
Fake news
One morning you will wake up to rdgl being between $2-$3 dollars. Sit back and accumulate shares
No expected dilution
Opinion
All 11k shares is massive lol
Agreed
Rdgl is definitely putting up some big claims. Sure hope they succeed in a timely fashion
Green Day
These words speak volumes to get YOUR SHARES NOW EVERYONE!
To bad we are not vvos today. But soon
Vivos Inc met with the Food and Drug Administration to obtain suggestions on improving the current draft of the Investigational Device Exemption, which is necessary to initiate clinical testing in humans. Two physicians from Mayo Clinic, Dr. Paz Fumagalli and Dr. Beau Toskich did an excellent job presenting the need for Radiogel™ to treat recurrent thyroid cancer and to answer a range of questions from the new FDA review team.
The FDA was very supportive and had suggested this Q-Submission path for rapid turnaround and dialog. The FDA provided many helpful suggestions on a range of subjects from labeling to dosimetry to the Mayo protocol for clinical testing, and the need for some additional specific testing. They suggested having another Q-Sub Review and conference call dedicated to the details of the dosimetry calculations.
Mike Korenko stated “Obtaining FDA approval is challenging, but we made significant progress with this meeting. This was the first time the Mayo Clinic Doctors met with the FDA regarding RadioGel. They were able to communicate the unmet medical need that RadioGel could address and successfully fielded several key questions from the FDA reviewers. If we did not take this interim step our IDE submittal would likely have been rejected and it would have cost us significantly more effort and time to recover. We already have sufficient funding in hand to complete all the scope necessary to submit the final IDE.”
Buyout potential